Société Générale Corporate & Investment Banking

Société Générale Corporate & Investment Banking (SG CIB) is the investment banking arm of the French financial services group Société Générale. While not a biotechnology or pharmaceutical company itself, SG CIB provides a wide range of financial services to the healthcare and life sciences sectors, including mergers and acquisitions (M&A) advisory, equity and debt capital markets, and specialized financing. The firm maintains a dedicated healthcare coverage team that supports global pharmaceutical, biotech, and medical technology companies in executing strategic transactions. SG CIB is a major player in European and global capital markets, facilitating investment and growth for healthcare innovators. Its services are essential for the capitalization and strategic expansion of companies across the healthcare value chain.